Title: Atherogenic Indices as Markers for Risk of Myocardial Infarction in Obese

Authors: Ayesha Jabeen, Gulam Saidunnisa Begum, J. Rama Rao

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i11.148

Abstract

The rising prevalence of obesity in India has a direct correlation with the increasing prevalence of obesity-related co-morbidities; hypertension, the metabolic syndrome, dyslipidemia, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD).

Methods: A case control study was conducted in the department of biochemistry, Osmania general hospital, Hyderabad with the objective of assessing the discriminatory power of atherogenic indices over individual lipids in risk assessment of Myocardial infarction in obese. Cases were categorized into obese and non obese MI group depending on the BMI. Control groups were selected from the outpatient department of Osmania General Hospital. Control groups were classified into healthy controls and obese controls basing on BMI.

Results: The mean values of BMI , WHR , TC , TAG, LDL-C ,CRR, AC, AIP are higher in obese controls  when compared to healthy controls,  HDL-C is lower  in obese control group when compared to healthy control group. The BMI exhibited better discriminatory power than WHR.  AIP and TAG exhibited the highest combined sensitivity and specificity followed by AC and CRR, TC and LDL-C in discriminating healthy controls and obese controls.  

Conclusion: We conclude the present study showed atherogenic indices were found to be better markers in explaining the pathogenesis of atherosclerosis. Among them AIP had the highest sensitivity and specificity followed by cardiac risk ratio, atherogenic coefficient and TAG in predicting the future risk of development of atherosclerosis in obese.

Keywords: Cardiac risk ratio (CRR), atherogenic coefficient (AC) and atherogenic index of plasma (AIP). Hypertension, metabolic syndrome, dyslipidemia, type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD)

References

  1. A Misra, P Chowbey .Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian Indians and Recommendations for Physical Activity, Medical and Surgical Management JAPI • VOL. 57 • FEBRUARY 2009
  2. S. Z. A. Shah, B. R. Devrajani Frequency of dyslipidemia in obese versus non - obese in relation to body mass index (BMI), waist hip ratio (WHR) and waist circumference(WC) Pakistan Journal of Science (Vol. 62 No. 1 March, 2010)
  3. F Magkos, BS Mohammed and B Mittendorfer Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women International Journal of Obesity (2008) 32, 1655–1664
  4. Van Gaal LF, Zhang A, Steijaert MM, De Leeuw IH  Human obesity: from lipid abnormalities to lipid oxidation. Int J Obes Relat Metab Disord. 1995 Sep;19 Suppl 3:S21-6.
  5. RS Gray, RR Fabsitz,, etal Relation of generalized and central obesity to cardiovascular risk factors and prevalent coronary heart disease in a sample of AmericanIndians: the Strong Heart StudyInternational Journal of Obesity (2000) 24, 849-860
  6. Boban Mathew etal  Obesity: Effects on Cardiovascular Disease and its Diagnosis J Am Board Fam Med 2008;21:562– 8.
  7. Sonia S. Anand Shofiqul Islam Annika Rosengren ,Risk factors for myocardial infarction in women and men: insights from the INTERHEART study Eur Heart J (2008)doi: 10.1093(8)
  8. RS Gray, RR Fabsitz,, etal Relation of generalized and central obesity to cardiovascular risk factors and prevalent coronary heart disease in a sample of AmericanIndians: the Strong Heart StudyInternational Journal of Obesity (2000) 24, 849-860
  9. Martirosyan, D. M., Miroshnichenko, L. A., Kulokawa, S. N., Pogojeva, A. V. and Zoloedov, V. I. (2007) Amaranth oil application for heart disease and hypertension. Lipids Health Dis. 6:1
  10. Chigozie jude ikewuchi and Chidinma catherine ikewuchi, Alteration of Plasma Lipid Profile and Atherogenic Indices of Cholesterol Loaded Rats by Tridax Procumbens Linn: Implications for the Management of Obesity and Cardiov-ascular Diseases MS/No BKM/2009/043, © 2009 Nigerian Society for Experimental Biology
  11. Jesús Millán,1 Xavier Pintó etal Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention Vasc Health Risk Manag. 2009; 5: 757–765.
  12. Molly c. carr and john d. brunzell .Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk  The Journal of Clinical Endocrinology & Metabolism 89(6):2601–2607
  13. S Johansson, G Bondjers etal Serum lipids and apolipoprotein levels in women with acute myocardial infarction Arterioscler Thromb Vasc Biol 1988, 8:742-749
  14. Assmann, G. and Gotto, A. M. Jr. (2004) HDL Cholesterol and Protective Factors in Atherosclerosis. Circulation 109[suppl III]:III-8–III-14 
  15. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet.  1975;1:16-20.
  16. Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive  summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497
  17. What do my cholesterol levels mean ? American Heart Association/ American stroke Associationurlhttp://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/What-Your-Cholesterol-Levels Mean_UCM_305562_Article.jsp 
  18. Dobiásová M. Atherogenic index of plasma [Log (triglycerides/HDL-cholesterol)]: theoretical and practical implications. Clin Chem. 2004;50:1113–1115.
  19. Herbert K.,Lipids, In Clinical Chemistry; Theory analysis and Co-relation,Kaplan L.A and Pesce AJ  Eds.,1984.p1182-1230.
  20. Friedwald W.T.,etal Chem 18,499(1972).
  21. Rifai N. Bachorik PS, Albers JJ. Lipids, lipoproteins and  apolipoproteins                    In: Burtis CA, Ashwood ER, editors. Teitz  Textbook of clinical chemistry 3rd ed. Philadelphia: W.BSaunders company;1999.p 809-61.
  22. Brehm, A., Pfeiler, G., Pacini, G., Vierhapper, H., and Roden, M. (2004) Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity. Clin. Chem. 50: 2316–2322 
  23. Hanumanthappa nandeesha ,Dr. Zachariah Bobby, etal Atherogenic lipid risk factors in men classifiedas overweight and obese according to the preliminary who guidelines for asiansIndian J Physiol Pharmacol 2008; 52 (2) : 205–208
  24. Ueshima H. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population.Circ 2006;70: 1249–1255.
  25. Jarosław Derejczyk1, Barbara Kłapcińska, Adolescent Obesity Predicts Cardiova-scular Risk Department of Physiological and Medical Sciences, Academy of Physical Education in KatowicePoland.
  26. Gianluca etal Comparison of Apolipoprotein (apoB/apoA-I) and Lipoprotein (Total Cholesterol/HDL) Ratio Determinants. Focus on Obesity, Diet and Alcohol Intake.plus.
  27. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol. 1991;68:1646–1650.
  28. Stanley H. Hsia, Deyu Pan, ET AL. A Population-Based, Cross-Sectional Comparison of Lipid-Related Indexes for Symptoms of Atherosclerotic Disease. American Journal of Cardiology Volume 98, Issue 8 , Pages 1047-1052, 15 October 2006
  29. Fadwa Essiarab, Hassan Taki etal , Usefulness of lipid ratios and atherogenic index of plasma in metabolic syndrome:The Moroccan investigation of cardiovascular diseases Laboratoire de Recherche sur les Lipoprotéines et l’Athérosclérose- Unité de Recherche Casablanca, Morocco

Corresponding Author

Gulam Saidunnisa Begum

Associate Professor, Department of Biochemistry,

Mahavir Institute of Medical sciences, Vikarabad, Telangana State, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.